薬物検査市場：薬物検査製品、サンプルタイプ、エンドユーザー別-2025-2030年の世界予測

薬物検査市場は、2023年に222億5,000万米ドルと評価され、2024年には249億4,000万米ドルに達すると予測され、CAGR 12.18%で成長し、2030年には497億6,000万米ドルに達すると予測されています。

薬物検査の適用範囲は、職場の安全、競技スポーツのコンプライアンス、リハビリテーションの推進における重要な役割にあります。薬物検査は、特定の物質の存在を特定するための生物学的サンプルの分析として定義され、労働安全基準の維持、法令遵守、個人の責任に必要です。その用途は、ヘルスケア、法執行機関、スポーツ、企業などのセクターにまたがり、最終用途は輸送から陸上競技まで多様な業界に及びます。薬物検査市場の成長には、薬物乱用の増加、規制要件の厳格化、安全な環境を確保し生産性を向上させるという雇用者の要求の高まりが主に寄与しています。効率性とプライバシーを重視する消費者の嗜好を反映し、迅速かつ非侵襲的な検査法などの先端技術の開発により、主な成長機会が生まれつつあります。市場関係者は、より迅速で正確な検査結果を得るために、AIと機械学習の統合をターゲットとした調査に投資すべきです。しかし、課題としては、プライバシーに関する倫理的懸念、高度な検査キットの高コスト、地域によって異なる法的複雑性などが挙げられます。また、検査結果に誤差が生じる可能性があることや、特定の検査範囲が限られていることが、市場の成長をさらに妨げています。技術革新の面では、安全なデータ処理のためのブロックチェーンや、検査の特異性を高めるためのバイオマーカー探索が市場の利益につながります。さらに、携帯可能なデジタル検査機器のイントロダクションは、個人や組織のコンプライアンス管理に革命をもたらす可能性があります。薬物検査市場の性質は競争であり、継続的な進歩と規制の変更により、ダイナミックな市場環境が維持されています。企業は、既存の機会を活用し、既存のギャップを効果的に埋めるために、進化する法規制の状況や技術の進歩に合わせて戦略を調整する必要があります。戦略的パートナーシップを結び、サービスの提供を拡大することで、市場の複雑さを乗り越え、この不可欠な業界の持続可能な成長を促進することができると思われます。

市場力学：急速に進化する薬物検査市場の主要市場インサイトを公開

薬物検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 薬物・アルコール消費量の増加
  • 薬物・アルコール検査に関する政府の厳しい規制
  • 薬事承認と製品・サービス開発の急増
• 市場抑制要因
  • 薬物検査は国によってはプライバシーの権利侵害にあたるため制限される
• 市場機会
  • 高度な薬物検査ソリューションの開発
  • インテリジェントな指紋認証薬物検査システム
• 市場の課題
  • スクリーニング検査の解釈における技術的問題と社会的問題

ポーターの5つの力：薬物検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：薬物検査市場における外部からの影響の把握

外部マクロ環境要因は、薬物検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析薬物検査市場における競合情勢の把握

薬物検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス薬物検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬物検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨薬物検査市場における成功への道筋を描く

薬物検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 薬物とアルコールの消費の増加
    • 薬物とアルコールの検査に関する厳格な政府規制
    • 規制当局の承認と製品・サービス開発の急増
  • 抑制要因
    • 一部の国ではプライバシー権の侵害となるため、薬物検査は制限されています
  • 機会
    • 高度な薬物検査ソリューションの開発
    • インテリジェント指紋薬物検査システム
  • 課題
    • スクリーニング検査の解釈における技術的問題と社会的問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 薬物検査市場薬物検査別製品

• アッセイキット
• 消耗品
• 薬物検査サービス
• 製品
  • 分析機器
    • アルコール検知器
    • クロマトグラフィー機器
    • 免疫測定分析装置
  • キャリブレーターとコントロール
  • 迅速検査装置
    • 口腔液検査装置
    • 尿検査装置
  • サンプル収集チューブ

第7章 薬物検査市場サンプルタイプ別

• 呼気サンプル
• 毛髪サンプル
• 口腔液サンプル
• 尿サンプル

第8章 薬物検査市場：エンドユーザー別

• 刑事司法制度と法執行機関
• 薬物検査研究室
• 薬物治療センター
• 病院
• 個人ユーザー
• 疼痛管理センター
• 大学
• 職場

第9章 南北アメリカの薬物検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の薬物検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの薬物検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Alfa Scientific Designs, Inc.
• Bio-Rad Laboratories, Inc.
• Clinical Reference Laboratory, Inc.
• Cordant Health Solutions
• Dragerwerk AG & Co. KGaA
• F. Hoffmann-La Roche AG
• Legacy Medical Services, LLC.
• Omega Laboratories, Inc.
• Quest Diagnostics
• Quidel Corporation
• Sciteck Clinical Laboratories
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. DRUG TESTING MARKET RESEARCH PROCESS
• FIGURE 2. DRUG TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CANADA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CANADA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 59. CANADA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. CANADA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CANADA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. CHINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. CHINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. CHINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 92. CHINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. CHINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. INDIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. INDIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. INDIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 98. INDIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. INDIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. INDIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. PHILIPPINES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SINGAPORE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH KOREA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TAIWAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 148. THAILAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. VIETNAM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. DENMARK DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. EGYPT DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. FINLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. FRANCE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 191. GERMANY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 197. ISRAEL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. ITALY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. ITALY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 200. ITALY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 201. ITALY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. ITALY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. ITALY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NETHERLANDS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 215. NIGERIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. NORWAY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. POLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. POLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 224. POLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 225. POLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. POLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 227. POLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. QATAR DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. QATAR DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 230. QATAR DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 231. QATAR DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. QATAR DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 233. QATAR DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 239. RUSSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SPAIN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. SWEDEN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 263. SWEDEN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. SWITZERLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 269. SWITZERLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 274. TURKEY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 275. TURKEY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 286. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 289. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Testing Market was valued at USD 22.25 billion in 2023, expected to reach USD 24.94 billion in 2024, and is projected to grow at a CAGR of 12.18%, to USD 49.76 billion by 2030.

The scope of drug testing lies in its crucial role in promoting workplace safety, compliance in competitive sports, and rehabilitation. Defined as the analysis of biological samples to identify the presence of specific substances, drug testing is necessary for maintaining occupational safety standards, legal compliance, and personal responsibility. Its applications are vast, spanning sectors like healthcare, law enforcement, sports, and corporate, with end-use encompassing diverse industries from transportation to athletics. The drug testing market's growth is primarily fueled by increased substance abuse, stringent regulatory requirements, and greater employer demand to ensure safer environments, enhancing productivity. Key growth opportunities are emerging with the development of advanced technology like rapid and non-invasive testing methods, reflecting consumer preferences towards efficiency and privacy. Market players should invest in research targeting the integration of AI and machine learning for quicker, more accurate test results. However, challenges include ethical concerns regarding privacy, the high cost of advanced testing kits, and legal complexities across different regions. The potential for error in test results and the limited scope of specific tests further hinder market growth. In terms of innovation, the market can benefit from exploring blockchain for secure data handling and biomarker discovery for enhanced testing specificity. Furthermore, the introduction of portable and digital testing devices could revolutionize personal and organizational compliance management. The nature of the drug testing market is competitive, with continuous advancements and regulatory changes maintaining dynamic market conditions. Companies need to tailor their strategies to the evolving legislative landscape and technological advancements to capitalize on existing opportunities and bridge existing gaps effectively. Engaging in strategic partnerships and expanding service offerings could help navigate market complexities and foster sustainable growth in this essential industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Testing Market

The Drug Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing drug & alcohol consumption
  • Stringent government regulations for drug & alcohol testing
  • Surge in regulatory approvals and product & service development
• Market Restraints
  • Restriction on the drug testing as it is violation of privacy rights in some countries
• Market Opportunities
  • Development of advanced drug testing solutions
  • Intelligent fingerprint drug testing system
• Market Challenges
  • Technical problem in interpreting screening tests and social issue

Porter's Five Forces: A Strategic Tool for Navigating the Drug Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Testing Market

A detailed market share analysis in the Drug Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Testing Market

A strategic analysis of the Drug Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Legacy Medical Services, LLC., Omega Laboratories, Inc., Quest Diagnostics, Quidel Corporation, Sciteck Clinical Laboratories, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Testing Product, market is studied across Assay Kits, Consumables, Drug Screening Services, and Products. The Products is further studied across Analytical Instruments, Calibrators & Controls, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices.
• Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.
• Based on End-User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Universities, and Workplace.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing drug & alcohol consumption
    • 5.1.1.2. Stringent government regulations for drug & alcohol testing
    • 5.1.1.3. Surge in regulatory approvals and product & service development
  • 5.1.2. Restraints
    • 5.1.2.1. Restriction on the drug testing as it is violation of privacy rights in some countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of advanced drug testing solutions
    • 5.1.3.2. Intelligent fingerprint drug testing system
  • 5.1.4. Challenges
    • 5.1.4.1. Technical problem in interpreting screening tests and social issue
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Testing Market, by Drug Testing Product

• 6.1. Introduction
• 6.2. Assay Kits
• 6.3. Consumables
• 6.4. Drug Screening Services
• 6.5. Products
  • 6.5.1. Analytical Instruments
    • 6.5.1.1. Breathalyzers
    • 6.5.1.2. Chromatography Instruments
    • 6.5.1.3. Immunoassay Analyzers
  • 6.5.2. Calibrators & Controls
  • 6.5.3. Rapid Testing Devices
    • 6.5.3.1. Oral Fluid Testing Devices
    • 6.5.3.2. Urine Testing Devices
  • 6.5.4. Sample Collection Tubes

7. Drug Testing Market, by Sample Type

• 7.1. Introduction
• 7.2. Breath Samples
• 7.3. Hair Samples
• 7.4. Oral Fluid Samples
• 7.5. Urine Samples

8. Drug Testing Market, by End-User

• 8.1. Introduction
• 8.2. Criminal Justice Systems & Law Enforcement Agencies
• 8.3. Drug Testing Laboratories
• 8.4. Drug Treatment Centers
• 8.5. Hospitals
• 8.6. Individual Users
• 8.7. Pain Management Centers
• 8.8. Universities
• 8.9. Workplace

9. Americas Drug Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Alfa Scientific Designs, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. Clinical Reference Laboratory, Inc.
• 6. Cordant Health Solutions
• 7. Dragerwerk AG & Co. KGaA
• 8. F. Hoffmann-La Roche AG
• 9. Legacy Medical Services, LLC.
• 10. Omega Laboratories, Inc.
• 11. Quest Diagnostics
• 12. Quidel Corporation
• 13. Sciteck Clinical Laboratories
• 14. Siemens Healthineers AG
• 15. Thermo Fisher Scientific Inc.